Treatment of Alzheimer's Disease With CX516 (Ampalex)
Clinical trial NCT00001662 · COMPLETED
Trial details
- NCT number
- NCT00001662
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1996-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.